Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zentalis Pharmaceuticals (ZNTL) Return on Assets (2022 - 2025)

Historic Return on Assets for Zentalis Pharmaceuticals (ZNTL) over the last 4 years, with Q3 2025 value amounting to 0.44%.

  • Zentalis Pharmaceuticals' Return on Assets fell 600.0% to 0.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44%, marking a year-over-year decrease of 600.0%. This contributed to the annual value of 0.34% for FY2024, which is 1700.0% up from last year.
  • According to the latest figures from Q3 2025, Zentalis Pharmaceuticals' Return on Assets is 0.44%, which was down 600.0% from 0.44% recorded in Q2 2025.
  • Zentalis Pharmaceuticals' Return on Assets' 5-year high stood at 0.37% during Q1 2024, with a 5-year trough of 0.55% in Q1 2025.
  • Over the past 4 years, Zentalis Pharmaceuticals' median Return on Assets value was 0.44% (recorded in 2023), while the average stood at 0.43%.
  • Per our database at Business Quant, Zentalis Pharmaceuticals' Return on Assets surged by 1100bps in 2024 and then plummeted by -1800bps in 2025.
  • Over the past 4 years, Zentalis Pharmaceuticals' Return on Assets (Quarter) stood at 0.41% in 2022, then dropped by -18bps to 0.49% in 2023, then rose by 22bps to 0.38% in 2024, then decreased by -17bps to 0.44% in 2025.
  • Its Return on Assets was 0.44% in Q3 2025, compared to 0.44% in Q2 2025 and 0.55% in Q1 2025.